• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在电生理实验室中不进行全身麻醉植入心脏复律除颤器的安全性。

Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory.

作者信息

Tung R T, Bajaj A K

机构信息

Electrophysiology Laboratories, Wesley Medical Center, Wichita, Kansas, USA.

出版信息

Am J Cardiol. 1995 May 1;75(14):908-12. doi: 10.1016/s0002-9149(99)80685-7.

DOI:10.1016/s0002-9149(99)80685-7
PMID:7732999
Abstract

Implantable cardioverter-defibrillators (ICDs) have conventionally been implanted in an operating room under general anesthesia. This study was performed to evaluate ICD implantation without general anesthesia by 2 electrophysiologists in an electrophysiology laboratory. Between February and September 1994, 27 consecutive patients (22 men and 5 women, mean age 59 +/- 15 years) who underwent ICD implantation by 2 electrophysiologists were included in this study. Fourteen patients received biphasic waveform ICDs, and the remaining 13 had monophasic waveform devices. All patients received local anesthesia and intravenous sedation for implantation. Implantation was successful in 23 of 27 patients at first attempt (11 of 11 with biphasic and 12 of 16 with monophasic waveform ICDs, respectively). Of 4 patients in whom implantation was initially unsuccessful, 3 subsequently received biphasic devices and 1 had improved defibrillation threshold ( < or = 26 J) on repeat testing after amiodarone withdrawal. Mean implantation time was 128 +/- 51 minutes, with 132 +/- 35 minutes under sedation. Patients who received biphasic versus monophasic waveform ICDs had no significant differences in mean sedation or implantation time. Minor complications occurred in 2 patients (7%): 1 minor abdominal pocket hematoma and 1 incision-site cellulitis. Mean time from implantation to discharge was 2.5 +/- 2.1 days. During late follow-up (n = 23; mean 12.4 +/- 5.8 weeks), all devices were functioning appropriately. In conclusion, this report demonstrates that ICD implantation can be successfully and safely performed by a team of 2 electrophysiologists using local anesthesia and intravenous sedation.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

植入式心脏复律除颤器(ICD)传统上是在手术室全身麻醉下植入的。本研究旨在评估两名电生理学家在电生理实验室中在无全身麻醉的情况下植入ICD的情况。1994年2月至9月,本研究纳入了由两名电生理学家连续进行ICD植入的27例患者(22例男性和5例女性,平均年龄59±15岁)。14例患者接受双相波形ICD,其余13例使用单相波形设备。所有患者植入时均接受局部麻醉和静脉镇静。27例患者中有23例首次植入成功(双相波形ICD的11例中11例成功,单相波形ICD的16例中12例成功)。4例最初植入失败的患者中,3例随后接受了双相设备,1例在停用胺碘酮后重复测试时除颤阈值改善(≤26J)。平均植入时间为128±51分钟,镇静下为132±35分钟。接受双相波形与单相波形ICD的患者在平均镇静或植入时间上无显著差异。2例患者(7%)出现轻微并发症:1例轻微腹部囊袋血肿和1例切口部位蜂窝织炎。植入至出院的平均时间为2.5±2.1天。在后期随访(n = 23;平均12.4±5.8周)期间,所有设备均运行正常。总之,本报告表明,由两名电生理学家组成的团队使用局部麻醉和静脉镇静可以成功、安全地进行ICD植入。(摘要截断于250字)

相似文献

1
Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory.在电生理实验室中不进行全身麻醉植入心脏复律除颤器的安全性。
Am J Cardiol. 1995 May 1;75(14):908-12. doi: 10.1016/s0002-9149(99)80685-7.
2
Subcutaneous single-incision implantation of cardioverter-defibrillators under local anesthesia by electrophysiologists in the electrophysiology laboratory.电生理学家在电生理实验室局部麻醉下经皮下单切口植入心脏复律除颤器。
Am J Cardiol. 1998 Feb 1;81(3):302-5. doi: 10.1016/s0002-9149(97)00918-1.
3
Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators.电生理实验室,电生理学家植入的,非开胸植入式心脏复律除颤器。
Circulation. 1994 Jun;89(6):2503-8. doi: 10.1161/01.cir.89.6.2503.
4
Electrophysiologist-implanted transvenous cardioverter defibrillators using local versus general anesthesia.
Pacing Clin Electrophysiol. 2000 Jan;23(1):96-105. doi: 10.1111/j.1540-8159.2000.tb00654.x.
5
Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique.采用肌间技术进行皮下植入式心律转复除颤器植入时的清醒镇静。
J Interv Card Electrophysiol. 2019 Jan;54(1):59-64. doi: 10.1007/s10840-018-0445-9. Epub 2018 Sep 14.
6
Implantation of a unipolar cardioverter/defibrillator system under local anaesthesia.在局部麻醉下植入单极心脏复律除颤器系统。
Eur Heart J. 1996 May;17(5):764-8. doi: 10.1093/oxfordjournals.eurheartj.a014944.
7
Transvenous defibrillator systems implanted by electrophysiologists in the catheterization laboratory.由电生理学家在导管室植入的经静脉除颤器系统。
Clin Cardiol. 1997 Feb;20(2):117-24. doi: 10.1002/clc.4960200207.
8
Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems.电生理学家对100台采用非开胸导联系统的连续心脏复律除颤器进行植入操作。
Circulation. 1994 Aug;90(2):868-72. doi: 10.1161/01.cir.90.2.868.
9
Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.皮下植入式心脏复律除颤器放置的麻醉管理:单中心经验。
J Clin Anesth. 2016 Jun;31:53-9. doi: 10.1016/j.jclinane.2015.11.009. Epub 2016 Mar 22.
10
Safety and acceptability of implantation of internal cardioverter-defibrillators under local anesthetic and conscious sedation.局部麻醉和清醒镇静下植入体内心脏复律除颤器的安全性和可接受性。
Pacing Clin Electrophysiol. 2007 Aug;30(8):992-7. doi: 10.1111/j.1540-8159.2007.00797.x.

引用本文的文献

1
Evidence-Based Strategies to Promote Long-Term Cardiac Implant Site Health: Review of the Literature.促进心脏植入长期部位健康的循证策略:文献综述
Cureus. 2021 Jan 31;13(1):e13027. doi: 10.7759/cureus.13027.
2
Perioperative management for the prevention of bacterial infection in cardiac implantable electronic device placement.心脏植入式电子设备植入术中预防细菌感染的围手术期管理。
J Arrhythm. 2016 Aug;32(4):283-6. doi: 10.1016/j.joa.2015.06.007. Epub 2015 Aug 8.
3
Efficacy and feasibility of the submuscular implantation technique for an implantable cardiac electrical device.
植入式心脏电子设备肌下植入技术的有效性和可行性
Eplasty. 2014 Oct 30;14:e40. eCollection 2014.
4
Safe and effective use of conscious sedation for defibrillation threshold testing during ICD implantation.在植入式心律转复除颤器(ICD)植入过程中,安全有效地使用清醒镇静进行除颤阈值测试。
J Saudi Heart Assoc. 2010 Oct;22(4):209-13. doi: 10.1016/j.jsha.2010.07.004. Epub 2010 Aug 8.
5
[Influence of waveform and configuration of electrodes on the defibrillation threshold of implantable cardioverter-defibrillators].[电极波形和配置对植入式心脏复律除颤器除颤阈值的影响]
Herzschrittmacherther Elektrophysiol. 1997 Mar;8(1):15-31. doi: 10.1007/BF03042474.
6
[Single- and dual-chamber ICDs: Are there still significant differences compared to pacemakers with regard to implantation and follow-up?].[单腔和双腔植入式心律转复除颤器:与起搏器相比,在植入和随访方面是否仍存在显著差异?]
Herzschrittmacherther Elektrophysiol. 2008 Dec;19 Suppl 1:6-13. doi: 10.1007/s00399-008-0610-4.
7
Intravenous sedation for cardiac procedures can be administered safely and cost-effectively by non-anesthesia personnel.心脏手术的静脉镇静可由非麻醉人员安全且经济高效地实施。
J Interv Card Electrophysiol. 2008 Jan;21(1):43-51. doi: 10.1007/s10840-007-9191-0. Epub 2008 Feb 14.
8
Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom?植入式心脏复律除颤器的除颤测试:何时进行、如何进行以及由谁进行?
Indian Pacing Electrophysiol J. 2007 Aug 1;7(3):166-75.
9
Safety and potential cost savings of same-setting electrophysiologic testing and placement of transvenous implantable cardioverter-defibrillators.同场所进行电生理检查及经静脉植入式心律转复除颤器置入的安全性及潜在成本节约
Clin Cardiol. 2001 Sep;24(9):592-6. doi: 10.1002/clc.4960240905.
10
A comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of costs and outcomes.
J Interv Card Electrophysiol. 1998 Dec;2(4):345-9. doi: 10.1023/a:1009756520054.